Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
The efficacy of chemotherapy in pediatric acute lymphoblastic leukemia (ALL) patients has significantly increased in the last twenty years; as a result, the focus of research is slowly shifting from trying to increase survival rates to reduce chemotherapy-related toxicity.At the present time, the co...
Main Authors: | Guillermo eGervasini, Jose Manuel Vagace |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-11-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fgene.2012.00249/full |
Similar Items
-
Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia
by: Vasiliki Karpa, et al.
Published: (2023-11-01) -
Association between the <i>TPMT*3C</i> (rs1142345) Polymorphism and the Risk of Death in the Treatment of Acute Lymphoblastic Leukemia in Children from the Brazilian Amazon Region
by: Darlen Cardoso de Carvalho, et al.
Published: (2020-09-01) -
Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
by: Gabriela Burgueño-Rodríguez, et al.
Published: (2023-11-01) -
Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
by: Patrycja Śliwa-Tytko, et al.
Published: (2022-05-01) -
Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia
by: Min Zhan, et al.
Published: (2023-06-01)